Isosorbide-5-mononitrate 50 mg for the management of coronary aretry disease. In biphasic release formulation, 30% immediate release & 70% sustained release to provide risk adjusted protection with once daily dosage and nitrate free interval.
Isosorbide 5-mononitrate 50 mg in biphasic release formulation, 30% immediate release & 70% sustained release for risk adjusted protection.
Long term treatment of coronary artery disease. Prophylaxis of anginal attacks; post-treatment of myocardial infarction with persisting anginal symptoms; long term treatment of chronic congestive heart failure in combination with digitalis and/or diuretics; chronic cor pulmonale.
Headache (less frequent than with others) & subsides gradually upon continuing treatment).
Dosage and Administration
One to two capsules once daily.
In the Most recent Guidelines of the European Society of Cardiology (SCAD) for the management of Stable Coronary Aretry Disease (SCAD);
Nitrates were recommended for the relief of Angina/ Ischaemia.
Deponit is the latest generation in transdermal nitrate patches, manufactured with high technology to provide optimum compliance to the patient with minimal patch size and thickness, together with consistent nitrate release.
Effox provides long-term treatment of coronary artery diseases (ex: Angina pectoris), its is composed of Isosorbide mononitrate; unlike dinitrates it has no first pass metabolism , thus providing 100% Bioavailability with an onset of action within 20 minutes of administration, and a dose of one tablet twice daily.
Lipanthyl 300 is recommended for the treatment of hypercholesterolaemia (abnormally elevated levels of cholesterol in blood) and/or hypertriglyceridaemia (abnormally elevated levels of triglycerides).
Minapharm organized this event in collaboration with Repro IVF Center
The Therapeutic focus of Minapharm in the field of gynecology
Latest updates in diagnosis and treatment of diverticular disease of
Stay connected, subscribe to our newsletter for news and updates.